Non-Syndromic Hearing Loss therapy (Prime Medicine)

N/A

Report date: 2024/09/04 15:10:15

Base Information

Drug NameNon-Syndromic Hearing Loss therapy (Prime Medicine)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrime Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrime Medicine Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A